The future of GLP-1 agonist therapy holds exciting possibilities: Expanded indications: Ongoing research is exploring the potential of GLP-1 agonists in treating a wide range of conditions, from neurodegenerative diseases to psychiatric disorders
Intensive research efforts are required to meet the demand of identifying novel eryptosis-associated kinases and investigating their potential pharmaceutical targetability
5-Amino-1MQ: How to Block the Enzyme That Stores Fat Learn how 5-amino-1MQ blocks NNMT enzyme to prevent fat storage, boost NAD+, improve metabolism
Inadequate use of newer treatments and glycemic control by cardiovascular risk and sociodemographic groups in US adults with diabetes in the NIH Precision Medicine Initiative All of Us Research Program
The Journal of Physiology, 589(4), 963-973.
Samocha-Bonet D, Chisholm DJ, Holst JJ, Greenfield JR